{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T13:03:36Z","timestamp":1780319016854,"version":"3.54.1"},"reference-count":56,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007313","name":"University of Texas MD Anderson Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Magnetic Resonance Imaging Clinics of North America"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.mric.2025.07.002","type":"journal-article","created":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T06:57:43Z","timestamp":1755241063000},"page":"595-612","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Current Applications of Molecular Imaging in Adrenal Imaging"],"prefix":"10.1016","volume":"33","author":[{"given":"Christine","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhayman","family":"Sadiq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Ravizzini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Ebada","family":"Salem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.mric.2025.07.002_bib1","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.2214\/AJR.07.2799","article-title":"The incidental adrenal mass on CT: prevalence of adrenal disease in 1,049 consecutive adrenal masses in patients with no known malignancy","volume":"190","author":"Song","year":"2008","journal-title":"AJR Am J Roentgenol"},{"issue":"9","key":"10.1016\/j.mric.2025.07.002_bib2","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.3390\/diagnostics12092171","article-title":"Adrenal lesions: a review of imaging","volume":"12","author":"Bracci","year":"2022","journal-title":"Diagnostics (Basel)"},{"issue":"1","key":"10.1016\/j.mric.2025.07.002_bib3","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1093\/ejendo\/lvad066","article-title":"European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors","volume":"189","author":"Fassnacht","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.mric.2025.07.002_bib4","doi-asserted-by":"crossref","first-page":"554","DOI":"10.2214\/AJR.15.14467","article-title":"Imaging features of various adrenal neoplastic lesions on radiologic and nuclear medicine imaging","volume":"205","author":"Shin","year":"2015","journal-title":"AJR Am J Roentgenol"},{"issue":"3","key":"10.1016\/j.mric.2025.07.002_bib5","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1210\/endrev\/bnae001","article-title":"Imaging of pheochromocytomas and paragangliomas","volume":"45","author":"Timmers","year":"2024","journal-title":"Endocr Rev"},{"issue":"2","key":"10.1016\/j.mric.2025.07.002_bib6","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ucl.2025.01.001","article-title":"Adrenal anatomy and physiology","volume":"52","author":"Al-Khanaty","year":"2025","journal-title":"Urol Clin North Am"},{"issue":"2","key":"10.1016\/j.mric.2025.07.002_bib7","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00441-018-2791-4","article-title":"Molecular imaging and theranostic approaches in pheochromocytoma and paraganglioma","volume":"372","author":"Ta\u00efeb","year":"2018","journal-title":"Cell Tissue Res"},{"issue":"8","key":"10.1016\/j.mric.2025.07.002_bib8","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.2967\/jnumed.120.259689","article-title":"Imaging of pheochromocytoma and paraganglioma","volume":"62","author":"Carrasquillo","year":"2021","journal-title":"J Nucl Med"},{"issue":"5","key":"10.1016\/j.mric.2025.07.002_bib9","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1007\/s12350-015-0170-z","article-title":"Impact of medications on mIBG uptake, with specific attention to the heart: comprehensive review of the literature","volume":"22","author":"Jacobson","year":"2015","journal-title":"J Nucl Cardiol"},{"issue":"1","key":"10.1016\/j.mric.2025.07.002_bib10","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0001-2998(05)80157-6","article-title":"The biodistribution of metaiodobenzylguanidine","volume":"22","author":"Parisi","year":"1992","journal-title":"Semin Nucl Med"},{"issue":"5","key":"10.1016\/j.mric.2025.07.002_bib11","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1053\/j.semnuclmed.2011.05.003","article-title":"Radioiodinated metaiodobenzylguanidine (MIBG): radiochemistry, biology, and pharmacology","volume":"41","author":"Vallabhajosula","year":"2011","journal-title":"Semin Nucl Med"},{"issue":"10","key":"10.1016\/j.mric.2025.07.002_bib12","first-page":"1735","article-title":"Iodine-131-metaiodobenzylguanidine and bone scintigraphy for the detection of neuroblastoma","volume":"33","author":"Shulkin","year":"1992","journal-title":"J Nucl Med"},{"issue":"7","key":"10.1016\/j.mric.2025.07.002_bib13","doi-asserted-by":"crossref","DOI":"10.1148\/rg.220191","article-title":"Adrenal neoplasms: Lessons from adrenal multidisciplinary tumor Boards","volume":"43","author":"Chung","year":"2023","journal-title":"Radiographics"},{"issue":"4","key":"10.1016\/j.mric.2025.07.002_bib14","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1007\/s00261-019-02082-4","article-title":"Mimics, pitfalls, and misdiagnoses of adrenal masses on CT and MRI","volume":"45","author":"Elsayes","year":"2020","journal-title":"Abdom Radiol (NY)"},{"issue":"1","key":"10.1016\/j.mric.2025.07.002_bib15","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1530\/ERC-11-0243","article-title":"False-negative 123I-MIBG SPECT is most commonly found in SDHB-related pheochromocytoma or paraganglioma with high frequency to develop metastatic disease","volume":"19","author":"Fonte","year":"2012","journal-title":"Endocr Relat Cancer"},{"issue":"4","key":"10.1016\/j.mric.2025.07.002_bib16","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1148\/radiographics.21.4.g01jl21995","article-title":"State-of-the-art adrenal imaging","volume":"21","author":"Mayo-Smith","year":"2001","journal-title":"Radiographics"},{"key":"10.1016\/j.mric.2025.07.002_bib17","series-title":"StatPearls [Internet]","article-title":"Octreotide scan. 2025 may 4","author":"Kapoor","year":"2025"},{"issue":"1","key":"10.1016\/j.mric.2025.07.002_bib18","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s12020-024-04042-5","article-title":"[18F]FDG-PET\/CT in adrenal lesions: diagnostic performance in different clinical settings","volume":"87","author":"Romanisio","year":"2025","journal-title":"Endocrine"},{"key":"10.1016\/j.mric.2025.07.002_bib19","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1749-6632.2002.tb04422.x","article-title":"The role of PET in localization of neuroendocrine and adrenocortical tumors","volume":"970","author":"Eriksson","year":"2002","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"10.1016\/j.mric.2025.07.002_bib20","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1055\/s-2005-870156","article-title":"New insights in the genetics of adrenocortical tumors, pheochromocytomas and paragangliomas","volume":"37","author":"Bertherat","year":"2005","journal-title":"Horm Metab Res"},{"issue":"1","key":"10.1016\/j.mric.2025.07.002_bib21","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1530\/eje.0.1470013","article-title":"Functional scintigraphy of the adrenal gland","volume":"147","author":"Rubello","year":"2002","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.1016\/j.mric.2025.07.002_bib22","doi-asserted-by":"crossref","first-page":"711","DOI":"10.2967\/jnumed.108.060731","article-title":"18F-FDG avidity of pheochromocytomas and paragangliomas: a new molecular imaging signature?","volume":"50","author":"Fakhry","year":"2009","journal-title":"J Nucl Med"},{"issue":"1","key":"10.1016\/j.mric.2025.07.002_bib23","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40644-016-0084-2","article-title":"(68)Ga-DOTATATE and (18)F-FDG PET\/CT in Paraganglioma and Pheochromocytoma: utility, patterns and heterogeneity","volume":"16","author":"Chang","year":"2016","journal-title":"Cancer Imaging"},{"issue":"6","key":"10.1016\/j.mric.2025.07.002_bib24","doi-asserted-by":"crossref","first-page":"872","DOI":"10.2967\/jnumed.115.165803","article-title":"68Ga-DOTATATE compared with 111In-DTPA-octreotide and conventional imaging for pulmonary and gastroenteropancreatic neuroendocrine tumors: a systematic review and meta-analysis","volume":"57","author":"Deppen","year":"2016","journal-title":"J Nucl Med"},{"issue":"2","key":"10.1016\/j.mric.2025.07.002_bib25","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1148\/rg.352140164","article-title":"Somatostatin receptor imaging with 68Ga DOTATATE PET\/CT: clinical utility, normal patterns, pearls, and pitfalls in interpretation","volume":"35","author":"Hofman","year":"2015","journal-title":"Radiographics"},{"issue":"3","key":"10.1016\/j.mric.2025.07.002_bib26","first-page":"369","article-title":"18F-FDOPA PET\/CT imaging of pheochromocytoma and paraganglioma: a systematic review and meta-analysis","volume":"60","author":"Ta\u00efeb","year":"2019","journal-title":"J Nucl Med"},{"issue":"10","key":"10.1016\/j.mric.2025.07.002_bib27","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1210\/clinem\/dgad166","article-title":"Metastatic pheochromocytoma and paraganglioma: somatostatin receptor 2 expression, genetics, and therapeutic responses","volume":"108","author":"Fischer","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.mric.2025.07.002_bib28","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1210\/jc.2011-1537","article-title":"Evaluation of the sensitivity and specificity of (11)C-metomidate positron emission tomography (PET)-CT for lateralizing aldosterone secretion by Conn\u2019s adenomas","volume":"97","author":"Burton","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.mric.2025.07.002_bib29","doi-asserted-by":"crossref","first-page":"770","DOI":"10.3389\/fonc.2019.00770","article-title":"CXCR4-Directed imaging in solid tumors","volume":"9","author":"Werner","year":"2019","journal-title":"Front Oncol"},{"issue":"8","key":"10.1016\/j.mric.2025.07.002_bib30","first-page":"1213","article-title":"18F-FACBC PET imaging in patients with adrenal lesions: preliminary experience","volume":"42","author":"Turkbey","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1016\/j.mric.2025.07.002_bib31","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2967\/jnumed.120.243139","article-title":"124I-MIBG PET\/CT to monitor metastatic disease in children with relapsed neuroblastoma","volume":"62","author":"Aboian","year":"2021","journal-title":"J Nucl Med"},{"key":"10.1016\/j.mric.2025.07.002_bib32","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s00259-017-3919-6","article-title":"Antitumor effects of radionuclide treatment using \u03b1-emitting meta-211At-astato-benzylguanidine in a PC12 pheochromocytoma model","volume":"45","author":"Ohshima","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"11","key":"10.1016\/j.mric.2025.07.002_bib33","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1158\/1078-0432.CCR-20-3703","article-title":"High-Specific-Activity-131I-MIBG versus 177Lu-DOTATATE targeted radionuclide therapy for metastatic pheochromocytoma and paraganglioma","volume":"27","author":"Jha","year":"2021","journal-title":"Clin Cancer Res"},{"issue":"Suppl 1","key":"10.1016\/j.mric.2025.07.002_bib34","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00259-011-2013-8","article-title":"111In-DTPA0-octreotide (Octreoscan), 131I-MIBG and other agents for radionuclide therapy of NETs","volume":"39","author":"Bomanji","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"10.1016\/j.mric.2025.07.002_bib36","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3390\/ph12030114","article-title":"Lutathera\u00ae: the first FDA- and EMA-approved radiopharmaceutical for PRRT","volume":"12","author":"Hennrich","year":"2019","journal-title":"Pharmaceuticals (Basel)"},{"issue":"2","key":"10.1016\/j.mric.2025.07.002_bib37","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa1607427","article-title":"Phase 3 trial of 177Lu-dotatate for Midgut neuroendocrine tumors","volume":"376","author":"Strosberg","year":"2017","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.mric.2025.07.002_bib38","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s00261-019-02048-6","article-title":"Adrenocortical hyperplasia: a review of clinical presentation and imaging","volume":"45","author":"Morani","year":"2020","journal-title":"Abdom Radiol (NY)"},{"issue":"8","key":"10.1016\/j.mric.2025.07.002_bib39","doi-asserted-by":"crossref","first-page":"599","DOI":"10.2165\/00128072-200103080-00005","article-title":"Congenital adrenal hyperplasia: epidemiology, management and practical drug treatment","volume":"3","author":"Merke","year":"2001","journal-title":"Paediatr Drugs"},{"issue":"4","key":"10.1016\/j.mric.2025.07.002_bib40","doi-asserted-by":"crossref","first-page":"M33","DOI":"10.1530\/EJE-15-0464","article-title":"Cushing\u2019s syndrome: update on signs, symptoms and biochemical screening","volume":"173","author":"Nieman","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"10.1016\/j.mric.2025.07.002_bib41","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s40618-020-01198-5","article-title":"Radiologically defined lipid-poor adrenal adenomas: histopathological characteristics","volume":"43","author":"De Leo","year":"2020","journal-title":"J Endocrinol Investig"},{"issue":"2","key":"10.1016\/j.mric.2025.07.002_bib42","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1148\/radiol.2382041514","article-title":"Distinguishing benign from malignant adrenal masses: multi-detector row CT protocol with 10-minute delay","volume":"238","author":"Blake","year":"2006","journal-title":"Radiology"},{"issue":"12","key":"10.1016\/j.mric.2025.07.002_bib43","doi-asserted-by":"crossref","first-page":"4551","DOI":"10.1210\/jc.2013-3020","article-title":"Update in adrenocortical carcinoma","volume":"98","author":"Fassnacht","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.mric.2025.07.002_bib44","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1210\/er.2013-1029","article-title":"Adrenocortical carcinoma","volume":"35","author":"Else","year":"2014","journal-title":"Endocr Rev"},{"issue":"6","key":"10.1016\/j.mric.2025.07.002_bib45","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s12672-011-0091-5","article-title":"FDG PET in the management of patients with adrenal masses and adrenocortical carcinoma","volume":"2","author":"Deandreis","year":"2011","journal-title":"Horm Cancer"},{"issue":"5","key":"10.1016\/j.mric.2025.07.002_bib46","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/cen.14268","article-title":"Presentation, disease progression and outcomes of adrenal gland metastases","volume":"93","author":"Mao","year":"2020","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"11","key":"10.1016\/j.mric.2025.07.002_bib47","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S2213-8587(21)00178-9","article-title":"Adrenal myelolipomas","volume":"9","author":"Calissendorff","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"10.1016\/j.mric.2025.07.002_bib48","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1148\/rg.2018170132","article-title":"Updates in diagnosis, management, and treatment of neuroblastoma","volume":"38","author":"Swift","year":"2018","journal-title":"Radiographics"},{"issue":"1","key":"10.1016\/j.mric.2025.07.002_bib49","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1148\/rg.2016150099","article-title":"MIBG in neuroblastoma diagnostic imaging and therapy","volume":"36","author":"Sharp","year":"2016","journal-title":"Radiographics"},{"issue":"4","key":"10.1016\/j.mric.2025.07.002_bib50","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3390\/jpm11040270","article-title":"Nuclear medicine imaging in neuroblastoma: current status and new developments","volume":"11","author":"Samim","year":"2021","journal-title":"J Pers Med"},{"issue":"3","key":"10.1016\/j.mric.2025.07.002_bib51","doi-asserted-by":"crossref","first-page":"389","DOI":"10.4103\/jmas.JMAS_147_20","article-title":"Ganglioneuroma presenting as an adrenal incidentaloma: feasibility of adrenal-sparing surgery","volume":"17","author":"Ranjan","year":"2021","journal-title":"J Minim Access Surg"},{"issue":"9","key":"10.1016\/j.mric.2025.07.002_bib52","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/j.radcr.2020.06.057","article-title":"Catecholamine-secreting adrenal lipomatous ganglioneuroma: a case study","volume":"15","author":"Yamamoto","year":"2020","journal-title":"Radiol Case Rep"},{"issue":"13","key":"10.1016\/j.mric.2025.07.002_bib53","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.3390\/diagnostics13132190","article-title":"Imaging of ganglioneuroma: a literature review and a rare case of cystic presentation in an adolescent girl","volume":"13","author":"Pacella","year":"2023","journal-title":"Diagnostics (Basel)"},{"issue":"10","key":"10.1016\/j.mric.2025.07.002_bib54","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1002\/1097-0142(20010515)91:10<1905::AID-CNCR1213>3.0.CO;2-4","article-title":"Metabolic activity and clinical features of primary ganglioneuromas","volume":"91","author":"Geoerger","year":"2001","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.mric.2025.07.002_bib55","first-page":"103","article-title":"Adrenal lymphoma: presentation, management and prognosis","volume":"110","author":"Laurent","year":"2017","journal-title":"QJM"},{"issue":"12","key":"10.1016\/j.mric.2025.07.002_bib56","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1007\/s00277-013-1812-3","article-title":"Primary adrenal lymphoma: a systematic review","volume":"92","author":"Rashidi","year":"2013","journal-title":"Ann Hematol"},{"issue":"3","key":"10.1016\/j.mric.2025.07.002_bib57","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1148\/rg.343130127","article-title":"From the radiologic pathology archives: adrenal tumors and tumor-like conditions in the adult: radiologic-pathologic correlation","volume":"34","author":"Lattin","year":"2014","journal-title":"Radiographics"}],"container-title":["Magnetic Resonance Imaging Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064968925000650?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064968925000650?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T01:38:52Z","timestamp":1761356332000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1064968925000650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":56,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S1064968925000650"],"URL":"https:\/\/doi.org\/10.1016\/j.mric.2025.07.002","relation":{},"ISSN":["1064-9689"],"issn-type":[{"value":"1064-9689","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current Applications of Molecular Imaging in Adrenal Imaging","name":"articletitle","label":"Article Title"},{"value":"Magnetic Resonance Imaging Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mric.2025.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}